Navigation Links
FDA Issues Another Warning on Fake Version of Cancer Drug Avastin
Date:2/6/2013

WEDNESDAY, Feb. 6 (HealthDay News) -- Doctors need to be on the lookout for another counterfeit version of the injectable cancer drug Avastin (bevacizumab), the U.S. Food and Drug Administration warned on Wednesday.

Lab tests revealed that at least one batch of the counterfeit medicine -- distributed by the U.S. company Medical Device King (also known as Pharmalogical) -- contains no active ingredient.

The counterfeit bevacizumab is marketed as Roche's Altuzan, which is not approved for sale in the United States, the FDA noted. The only approved version of bevacizumab for sale in the United States is Avastin, which is marketed by Genentech.

Altuzan 400 mg/16 mL may be counterfeit if it is labeled as batch B6022B01 with an expiration date of November 2013 or batch B6024B01 with an expiration date of February 2013, the agency said.

The FDA also warned doctors, hospitals and patients to "be wary if the price of a medicine sounds too good to be true. Deep discounts may be offered because the product is stolen, counterfeit, substandard or unapproved."

The FDA said it doesn't know at this point if any patients were given the counterfeit version of the drug, the Associated Press reported. Avastin is used to treat colorectal, brain, lung and kidney cancers.

Medical practices that have received any products from Medical Device King, Pharmalogical or Taranis Medical (another company associated with Pharmalogical) should quit using these products because they might prove hazardous or ineffective, the FDA said.

Anyone with these medicines also should contact the FDA's Office of Criminal Investigations to arrange for pickup.

This is the third case of counterfeit Avastin being sold in the United States in the past year, the AP reported.

In February 2012, the agency said it was investigating a batch of counterfeit Avastin distributed to doctors in several states. In April 2012, the
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. UCSF chancellor issues call-to-arms to patient advocates
2. Radiologists rank themselves as less than competent on health policy issues
3. Genetic abnormalities in benign or malignant tissues predict relapse of prostate cancer
4. FDA Issues Multiple Sclerosis Drug Alert
5. Quality of care, other issues may cause worse results in black prostate cancer surgery patients
6. U.S. Task Force Issues Blood Pressure Guidelines
7. Internists in Washington to discuss patient and professional issues in meetings on Capitol Hill
8. Cheaper drug could lead to serious eye issues
9. Insulite Labs announces the launch of the PCOS Inspiration Hour, a one hour virtual gathering place for women with PCOS and other women’s health issues to come together.
10. LawyersandSettlements.com Issues Report on Prostate Health Claim Lawsuits and Propecia Side Effect Litigation
11. What Men Should Know About Veins: Varicose Veins and Venous Disease are Real Medical Issues
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA Issues Another Warning on Fake Version of Cancer Drug Avastin
(Date:7/6/2015)... ... July 06, 2015 , ... Olive Fertility Centre is ... 2014-2015 Post Graduate Teaching Award on behalf of the department of Family Practice. , ... exciting field to be practicing in. The technology is changing so rapidly and we ...
(Date:7/6/2015)... ... July 06, 2015 , ... Longevity, ... has partnered with Woodbridge Walk-In Urgent Care to offer on-site health screenings. These ... medical conditions. Screenings are affordable and accurate and run about an hour long ...
(Date:7/6/2015)... ... July 06, 2015 , ... Health care systems and genomics projects have generated ... to access and use this “Big Data” to improve health and cut costs is ... of the Mount Sinai Health System in New York City. Physicians will have these ...
(Date:7/6/2015)... ... July 06, 2015 , ... In a split second, breaking a ... their risk of having a fracture through the bone health screenings conducted by American ... “We are participating because our residents need this information to remain independent and strong ...
(Date:7/6/2015)... ... July 06, 2015 , ... World renowned Los ... to achieve their ideal appearance through comprehensive treatment solutions. Individuals that want to make ... doctor and receive a plan that resolves each of their needs. , "Anytime ...
Breaking Medicine News(10 mins):Health News:Olive Fertility Centre Physician Honoured for Teaching 2Health News:Woodbridge Walk-In Offers Affordable Early Detection Health Screenings Through Longevity 2Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 2Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 3Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 4Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 5Health News:National Bone Health Screening and Awareness Day 2Health News:Los Angeles Plastic Surgeon, Dr. Paul Nassif, is Now Offering Comprehensive Facial Plastic Surgery Procedures 2
... ... recently achieved the third largest civil damages award known in Berks County. The ... poorly designed machine. Attorney Jurewicz negotiated with the Austrian manufacturer of the machine ... , ...
... ... medical applications, introduces the ROHO Hybrid Elite cushion. The Hybrid Elite combines the superb ... a Jay® contoured foam base engineered specifically for ROHO. , ... Belleville, Ill. (PRWEB) November 17, 2009 -- ...
... PLAINS, N.Y., NOV. 17, 2009 For the second ... the March of Dimes Premature Birth Report Card, demonstrating that ... get the healthy start they deserved. In the 2009 ... one letter grade and two fared worse. Criteria that affect ...
... 16 Encorium Group, Inc. (Nasdaq: ENCO ), a ... over 30 countries for many of the world,s leading pharmaceutical ... third quarter ended September 30, 2009. , As previously announced, ... the assets relating to its US line of business to ...
... United American Healthcare Corporation (Nasdaq: UAHC ) today announced ... 30, 2009. , Revenues for the first quarter ... with revenues of $6.3 million for the first quarter of ... result of the complete transfer of TennCare enrollees served by ...
... , WEIFANG, China, Nov. 16 ... "the Company"),a leading manufacturer and distributor of high-quality, pharmaceutical grade,glucose ... of fiscal 2010 ended September 30, 2009. , , ... -- First quarter 2010 revenues totaled $23.13 million, ...
Cached Medicine News:Health News:Galfand Berger Personal Injury Lawyer Richard Jurewicz Obtains Record Recovery In Berks County 2Health News:The ROHO Group Introduces ROHO Hybrid Elite™ Two Trusted Brands; One Effective Cushion 2Health News:US gets a 'D' for preterm birth rate 2Health News:Encorium Reports Third Quarter 2009 Financial Results; Announces Date of Annual Stockholder Meeting 2Health News:Encorium Reports Third Quarter 2009 Financial Results; Announces Date of Annual Stockholder Meeting 3Health News:Encorium Reports Third Quarter 2009 Financial Results; Announces Date of Annual Stockholder Meeting 4Health News:Encorium Reports Third Quarter 2009 Financial Results; Announces Date of Annual Stockholder Meeting 5Health News:Encorium Reports Third Quarter 2009 Financial Results; Announces Date of Annual Stockholder Meeting 6Health News:Encorium Reports Third Quarter 2009 Financial Results; Announces Date of Annual Stockholder Meeting 7Health News:Encorium Reports Third Quarter 2009 Financial Results; Announces Date of Annual Stockholder Meeting 8Health News:Encorium Reports Third Quarter 2009 Financial Results; Announces Date of Annual Stockholder Meeting 9Health News:Encorium Reports Third Quarter 2009 Financial Results; Announces Date of Annual Stockholder Meeting 10Health News:Encorium Reports Third Quarter 2009 Financial Results; Announces Date of Annual Stockholder Meeting 11Health News:United American Healthcare Corporation Announces Fiscal 2010 First Quarter Results 2Health News:United American Healthcare Corporation Announces Fiscal 2010 First Quarter Results 3Health News:United American Healthcare Corporation Announces Fiscal 2010 First Quarter Results 4Health News:United American Healthcare Corporation Announces Fiscal 2010 First Quarter Results 5Health News:United American Healthcare Corporation Announces Fiscal 2010 First Quarter Results 6Health News:United American Healthcare Corporation Announces Fiscal 2010 First Quarter Results 7Health News:Shengtai Pharmaceutical, Inc. Reports First Quarter Fiscal Year 2010 Financial Results 2Health News:Shengtai Pharmaceutical, Inc. Reports First Quarter Fiscal Year 2010 Financial Results 3Health News:Shengtai Pharmaceutical, Inc. Reports First Quarter Fiscal Year 2010 Financial Results 4Health News:Shengtai Pharmaceutical, Inc. Reports First Quarter Fiscal Year 2010 Financial Results 5
(Date:7/6/2015)... July 6, 2015 E-QURE Corp (OTCQB: EQUR), ... live at VirtualInvestorConferences.com on July 9, 2015. ... http://tinyurl.com/e-qure-presentation This will be a ... ask the company questions in real-time - both in ... trade booth." If attendees are not able to join ...
(Date:7/6/2015)... -- Celtaxsys, Inc., a clinical stage pharmaceutical development company ... orphan inflammatory disease indications, announced today that it has ... (FDA) to begin a Phase 2 clinical trial of ... patients in the US. The regulatory submissions to the ... be filed soon after. This groundbreaking clinical study, testing ...
(Date:7/6/2015)... , July 6, 2015  OncoSec Medical Inc. ... intratumoral cancer immunotherapies, today announced the appointment of ... of Vice President of Market Development, effective July 6, ... for evaluating, designing, and executing on the company,s market ... "I,m very excited to welcome Joann to the ...
Breaking Medicine Technology:E-QURE Corp to Webcast, Live, at VirtualInvestorConferences.com July 9 2Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 2Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 3OncoSec Medical Appoints Joann V. Lofgren as Vice President of Market Development 2OncoSec Medical Appoints Joann V. Lofgren as Vice President of Market Development 3
... Portable Slit-Lamp. Rechargeable, cordless ... for any purpose , Easy selection ... blue filter , Extra-bright halogen lamp ... main and extra ,power pack , ...
The PillCam™ ESO video capsule is specifically designed to view the inner lining of the Esophagus. The capsule is equipped with miniature cameras on both ends and is about the size of a multi-v...
World's first commercially available vacuum assisted biopsy device for MRI....
... Now you can perform stereotactic, ultrasound ... the convenience of your office. Use the ... safer, easier and more clinically advanced method ... its best for the women who trust ...
Medicine Products: